Andy has worked as a strategy consultant in health and life sciences for over 25 years.  His work spans all areas of Research & Development and he is a recognised thought leader in drug development, patient engagement, pharma services, regulatory and pharmacovigilance operations.

​

Andy also chairs Lucid Group and Optibrium, is a Non-Executive Director at Datapharm Ltd and is Professor of Practice at King’s College London.

Previously Andy trained as a Surgeon, was a Consultant at Accenture, and co-founded and led Kinapse Ltd (now part of Syneos Health). 

​

Andy lives in the UK and is an enthusiastic, albeit wayward, golfer.

​

Andy Black | LinkedIn